Skip to main content
Erschienen in: European Journal of Pediatrics 7/2012

01.07.2012 | Original Article

Role of cytokine gene (IFN-γ, TNF-α, TGF-β1, IL-6, and IL-10) polymorphisms in pathogenesis of acute rheumatic fever in Turkish children

verfasst von: Nilgun Col-Araz, Sacide Pehlivan, Osman Baspinar, Sibel Oguzkan-Balci, Tugce Sever, Ayse Balat

Erschienen in: European Journal of Pediatrics | Ausgabe 7/2012

Einloggen, um Zugang zu erhalten

Abstract

Acute rheumatic fever (ARF) is a delayed immunologically mediated sequela of throat infection by group A β-hemolytic streptococci. Inflammatory cytokines may play a pathogenic role in ARF. The objective of this study was to investigate the potential associations between interferon (IFN)-γ, interleukin (IL)-6, tumor necrosis factor (TNF)-α, transforming growth factor (TGF)-β1, and IL-10 gene polymorphisms and childhood ARF. Thirty-eight ARF patients and 40 age- and sex-matched healthy controls were analyzed for eight polymorphisms in five different cytokine genes [IFN-γ (+874), IL-6 (−174), TNF-α (−308), TGF-β1 (+10, +25), and IL-10 (−1082, −819, −592)]. Cytokine genotyping was performed by polymerase chain reaction sequence-specific primer methods. Patients with ARF had significantly higher frequencies of IFN-γ (+874) polymorphism in both TT genotype (p = 0.0002) and T allele (p = 0.0004). No statistically significant differences were observed in genotypes, haplotypes, and allele frequencies of IL-6, TNF-α, TGF-β1, and IL-10 genes between ARF and control groups (p > 0.05). GG genotype frequency of TNF-α gene (low expression) was higher in patients who had previous ARF history (p = 0.006). High expression of TGF-β1 (TT/GG, TC/GG) was more frequent in patients with CRP positivity (p = 0.034). IL-6 CC genotype (low expression) frequency was higher in patients with tricuspid valve insufficiency (p = 0.002), while IFN-γ TT genotype (high expression) frequency was higher in patients with mitral valve prolapse (p = 0.049). Conclusion: High expression of the IFN-γ gene may carry a higher risk for ARF in Turkish children, while IL-6, TNF-α, and TGF-β1 may have an impact in mediating some clinical and laboratory manifestations of the disease.
Literatur
1.
Zurück zum Zitat Al-Tahhan MA, Etewa RL, El Behery MM (2011) Association between circulating interleukin-1 beta (IL-1β) levels and IL-1β C-511T polymorphism with cervical cancer risk in Egyptian women. Mol Cell Biochem 353:159–165PubMedCrossRef Al-Tahhan MA, Etewa RL, El Behery MM (2011) Association between circulating interleukin-1 beta (IL-1β) levels and IL-1β C-511T polymorphism with cervical cancer risk in Egyptian women. Mol Cell Biochem 353:159–165PubMedCrossRef
2.
Zurück zum Zitat Berdeli A, Tabel Y, Celik HA, Ozyurek R, Dogrusoz B, Aydin HH (2006) Lack of association between TNF α gene polymorphism at position −308 and risk of acute rheumatic fever in Turkish patients. Scand J Rheumatol 35:44–47PubMedCrossRef Berdeli A, Tabel Y, Celik HA, Ozyurek R, Dogrusoz B, Aydin HH (2006) Lack of association between TNF α gene polymorphism at position −308 and risk of acute rheumatic fever in Turkish patients. Scand J Rheumatol 35:44–47PubMedCrossRef
3.
Zurück zum Zitat Bernstein D (2008) Rheumatic hearth disease. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF (eds) Nelson textbook of pediatrics, 18th edn. Saunders Elsevier, Philadelphia, pp 1961–1963 Bernstein D (2008) Rheumatic hearth disease. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF (eds) Nelson textbook of pediatrics, 18th edn. Saunders Elsevier, Philadelphia, pp 1961–1963
4.
5.
Zurück zum Zitat Chou HT, Chen CH, Tsai CH, Tsai FJ (2004) Association between transforming growth factor-β1 gene C-509T and T869C polymorphisms and rheumatic heart disease. Am Heart J 148:181–186PubMedCrossRef Chou HT, Chen CH, Tsai CH, Tsai FJ (2004) Association between transforming growth factor-β1 gene C-509T and T869C polymorphisms and rheumatic heart disease. Am Heart J 148:181–186PubMedCrossRef
6.
Zurück zum Zitat Chou HT, Tsai CH, Chen WC, Tsai FJ (2005) Lack of association of genetic polymorphisms in the interleukin-1β, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 genes with risk of rheumatic heart disease in Taiwan Chinese. Int Heart J 46:397–406PubMedCrossRef Chou HT, Tsai CH, Chen WC, Tsai FJ (2005) Lack of association of genetic polymorphisms in the interleukin-1β, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 genes with risk of rheumatic heart disease in Taiwan Chinese. Int Heart J 46:397–406PubMedCrossRef
7.
Zurück zum Zitat Couper KN, Blount DG, Riley EM (2008) Il-10: the master regulator of immunity to infection. J Immunol 180:5771–5777PubMed Couper KN, Blount DG, Riley EM (2008) Il-10: the master regulator of immunity to infection. J Immunol 180:5771–5777PubMed
8.
Zurück zum Zitat Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P (1988) The effect of novel polymorphism in the interleukin-6 (IL-6) gene on IL-6 transkription and plasma IL-6 levels, and an association with systemic onset juvenile chronic arthritis. J Clin Invest 102:1369–1376CrossRef Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P (1988) The effect of novel polymorphism in the interleukin-6 (IL-6) gene on IL-6 transkription and plasma IL-6 levels, and an association with systemic onset juvenile chronic arthritis. J Clin Invest 102:1369–1376CrossRef
9.
Zurück zum Zitat Fonseca JE, Santos MJ, Canhao H, Choy E (2009) Interleukin-6 as a key player in systemic inflammation and joint destruction. Autoimmun Rev 8:538–542PubMedCrossRef Fonseca JE, Santos MJ, Canhao H, Choy E (2009) Interleukin-6 as a key player in systemic inflammation and joint destruction. Autoimmun Rev 8:538–542PubMedCrossRef
10.
Zurück zum Zitat Gaur U, Aggarwal BB (2003) Regulation of proliferation, survival and apoptozis by members of the TNF superfamily. Biochem Pharmacol 66:1403–1408PubMedCrossRef Gaur U, Aggarwal BB (2003) Regulation of proliferation, survival and apoptozis by members of the TNF superfamily. Biochem Pharmacol 66:1403–1408PubMedCrossRef
11.
Zurück zum Zitat Gerber MA (2008) Group A streptococcus. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF (eds) Nelson textbook of pediatrics, 18th edn. Saunders Elsevier, Philadelphia, pp 1135–1145 Gerber MA (2008) Group A streptococcus. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF (eds) Nelson textbook of pediatrics, 18th edn. Saunders Elsevier, Philadelphia, pp 1135–1145
12.
Zurück zum Zitat Golbasi Z, Ucar O, Keles T, Sahin A, Cagli K, Camsari A, Diker E, Aydogdu S (2002) Increased levels of high sensitive C-reactive protein in patients with chronic rheumatic valve disease: evidence of ongoing inflammation. Eur J Heart Fail 4:593–595PubMedCrossRef Golbasi Z, Ucar O, Keles T, Sahin A, Cagli K, Camsari A, Diker E, Aydogdu S (2002) Increased levels of high sensitive C-reactive protein in patients with chronic rheumatic valve disease: evidence of ongoing inflammation. Eur J Heart Fail 4:593–595PubMedCrossRef
13.
Zurück zum Zitat Guilherme L, Cunha-Neto E, Tanaka AC, Dulphy N, Toubert A, Kalil J (2001) Heart-directed autoimmunity: the case of rheumatic fever. J Autoimmun 16:363–367PubMedCrossRef Guilherme L, Cunha-Neto E, Tanaka AC, Dulphy N, Toubert A, Kalil J (2001) Heart-directed autoimmunity: the case of rheumatic fever. J Autoimmun 16:363–367PubMedCrossRef
14.
Zurück zum Zitat Guilherme L, Cury P, Demarchi LMF, Lopez AP, Oshiro SE, Aliotti S, Cunha-Neto A, Pomerantzeff PMA, Tanaka AC, Kalil J (2004) Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular disease. Am J Pathol 165:1583–1591PubMedCrossRef Guilherme L, Cury P, Demarchi LMF, Lopez AP, Oshiro SE, Aliotti S, Cunha-Neto A, Pomerantzeff PMA, Tanaka AC, Kalil J (2004) Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular disease. Am J Pathol 165:1583–1591PubMedCrossRef
15.
Zurück zum Zitat Guilherme L, Fae KC, Oshiro SE, Tanaka AC, Pomerantzeff PMA, Kalil J (2005) Rheumatic fever: how S. pyogenes-primed peripheral T cells trigger heart valve lesions. Ann N Y Acad Sci 1051:132–140PubMedCrossRef Guilherme L, Fae KC, Oshiro SE, Tanaka AC, Pomerantzeff PMA, Kalil J (2005) Rheumatic fever: how S. pyogenes-primed peripheral T cells trigger heart valve lesions. Ann N Y Acad Sci 1051:132–140PubMedCrossRef
16.
Zurück zum Zitat Guilherme L, Kalil J (2002) Rheumatic fever: the T cell response leading to autoimmune aggression in the hearth. Autoimmun Rev 1:261–266PubMedCrossRef Guilherme L, Kalil J (2002) Rheumatic fever: the T cell response leading to autoimmune aggression in the hearth. Autoimmun Rev 1:261–266PubMedCrossRef
17.
Zurück zum Zitat Guilherme L, Kalil J (2010) Rheumatic fever and rheumatic heart disease: cellular mechanisms leading autoimmune reactivity and disease. J Clin Immunol 30:17–23PubMedCrossRef Guilherme L, Kalil J (2010) Rheumatic fever and rheumatic heart disease: cellular mechanisms leading autoimmune reactivity and disease. J Clin Immunol 30:17–23PubMedCrossRef
18.
Zurück zum Zitat Guilherme L, Ramasawmy R, Kalil J (2007) Rheumatic fever and rheumatic hearth disease: genetics and pathogenesis. Scand J Immunol 66:199–207PubMedCrossRef Guilherme L, Ramasawmy R, Kalil J (2007) Rheumatic fever and rheumatic hearth disease: genetics and pathogenesis. Scand J Immunol 66:199–207PubMedCrossRef
19.
Zurück zum Zitat Hafez M, El-Morsy Z, El-Shennawy F, Hawas S, Sheishaa A, Abo-El-Kheir M, Shokeir M, Al-Marsafawy H, El-Baz R, Atia G (2002) Susceptibility to over production of cytokines in acute rheumatic carditis and their role in the pathogenesis. J Med Sci 2(2):65–73CrossRef Hafez M, El-Morsy Z, El-Shennawy F, Hawas S, Sheishaa A, Abo-El-Kheir M, Shokeir M, Al-Marsafawy H, El-Baz R, Atia G (2002) Susceptibility to over production of cytokines in acute rheumatic carditis and their role in the pathogenesis. J Med Sci 2(2):65–73CrossRef
20.
Zurück zum Zitat Hayek E, Gring CN, Griffin BD (2005) Mitral valve prolapse. Lancet 365:507–518PubMed Hayek E, Gring CN, Griffin BD (2005) Mitral valve prolapse. Lancet 365:507–518PubMed
21.
Zurück zum Zitat Hernandez-Pacheco G, Flores-Dominguez C, Rodriguez-Perez JM, Perez-Hernandez N, Fragoso JM, Saul A, Alvarez-Leon E, Granados J, Reyas PA, Vargas-Alarcon G (2003) Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with rheumatic heart disease. J Autoimmun 21:59–63PubMedCrossRef Hernandez-Pacheco G, Flores-Dominguez C, Rodriguez-Perez JM, Perez-Hernandez N, Fragoso JM, Saul A, Alvarez-Leon E, Granados J, Reyas PA, Vargas-Alarcon G (2003) Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with rheumatic heart disease. J Autoimmun 21:59–63PubMedCrossRef
22.
Zurück zum Zitat Terzi YK, Oguzkan-Balci S, Anlar B, Erdogan-Bakar E, Ayter S (2011) Learning disability and oligodendrocyte myelin glycoprotein (OMGP) gene in neurofibromatosis type 1. Turk J Pediatr 53:75–78 Terzi YK, Oguzkan-Balci S, Anlar B, Erdogan-Bakar E, Ayter S (2011) Learning disability and oligodendrocyte myelin glycoprotein (OMGP) gene in neurofibromatosis type 1. Turk J Pediatr 53:75–78
23.
Zurück zum Zitat Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA (2006) Transforming growth factor-beta regulation in immune responses. Annu Rev Immunol 24:99–146PubMedCrossRef Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA (2006) Transforming growth factor-beta regulation in immune responses. Annu Rev Immunol 24:99–146PubMedCrossRef
24.
Zurück zum Zitat Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215PubMedCrossRef Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215PubMedCrossRef
25.
Zurück zum Zitat Nasuti JF, Zhang PJ, Feldman MD, Pahsa T, Khurana JS, Gorman JH, Gorman RC, Narula J, Narula N (2004) Fibrillin and other matrix proteins in mitral valve prolapse syndrome. Ann Thorac Surg 77:532–536PubMedCrossRef Nasuti JF, Zhang PJ, Feldman MD, Pahsa T, Khurana JS, Gorman JH, Gorman RC, Narula J, Narula N (2004) Fibrillin and other matrix proteins in mitral valve prolapse syndrome. Ann Thorac Surg 77:532–536PubMedCrossRef
26.
Zurück zum Zitat Pehlivan M, Okan V, Sever T, Balcı SO, Yılmaz M, Babacan T, Pehlivan S (2011) Investigation of TNF-alpha, TGF-beta1, IL-10, IL-6, IF-gamma, MBL, GPIA, and IL1A gene polymorphisms in patients with idiopathic trombocytopenic purpura. Platelets. doi:10.3109/09537104.2011.577255 Pehlivan M, Okan V, Sever T, Balcı SO, Yılmaz M, Babacan T, Pehlivan S (2011) Investigation of TNF-alpha, TGF-beta1, IL-10, IL-6, IF-gamma, MBL, GPIA, and IL1A gene polymorphisms in patients with idiopathic trombocytopenic purpura. Platelets. doi:10.​3109/​09537104.​2011.​577255
27.
Zurück zum Zitat Pravica V, Asderakis A, Perry C, Hajeer A, Sinnott PJ, Hutchinson IV (1999) In vitro production of IFN-γ correlates with CA repeat polymorphisms in the human IFN-γ gene. Eur J Immunogenet 26:1–3PubMedCrossRef Pravica V, Asderakis A, Perry C, Hajeer A, Sinnott PJ, Hutchinson IV (1999) In vitro production of IFN-γ correlates with CA repeat polymorphisms in the human IFN-γ gene. Eur J Immunogenet 26:1–3PubMedCrossRef
28.
Zurück zum Zitat Ramasawmy R, Fae KC, Spina SG, Victoria GD, Tanaka AC, Palacios SA, Hounie AG, Miguel EC, Oshiro SA, Goldberg AC, Kalil J, Guilherme L (2007) Association of polymorphisms within the promoter region of the tumor necrosis factor-α with clinical outcomes of rheumatic fever. Mol Immunol 44:1873–1878PubMedCrossRef Ramasawmy R, Fae KC, Spina SG, Victoria GD, Tanaka AC, Palacios SA, Hounie AG, Miguel EC, Oshiro SA, Goldberg AC, Kalil J, Guilherme L (2007) Association of polymorphisms within the promoter region of the tumor necrosis factor-α with clinical outcomes of rheumatic fever. Mol Immunol 44:1873–1878PubMedCrossRef
29.
Zurück zum Zitat Sallakci N, Akcurin G, Köksoy S, Kardelen F, Uguz A, Coskun M, Ertug H, Yegin O (2005) TNF-alpha G-308A polymorphism is associated with rgeumatic fever and correlates with increased TNF-alpha production. J Autoimmun 25:150–154PubMedCrossRef Sallakci N, Akcurin G, Köksoy S, Kardelen F, Uguz A, Coskun M, Ertug H, Yegin O (2005) TNF-alpha G-308A polymorphism is associated with rgeumatic fever and correlates with increased TNF-alpha production. J Autoimmun 25:150–154PubMedCrossRef
30.
Zurück zum Zitat Schroder K, Hertzog PJ, Ravasi T, Hume DA (2004) Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75:163–189PubMedCrossRef Schroder K, Hertzog PJ, Ravasi T, Hume DA (2004) Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75:163–189PubMedCrossRef
31.
Zurück zum Zitat Settin A, Abdel-Hady H, El-baz R, Saber I (2007) Gene polymorphisms of TNF-α (−308), IL-10 (−1082), and IL-1Ra (VNTR) related to susceptibility and severity of rheumatic heart disease. Pediatr Cardiol 28:363–371PubMedCrossRef Settin A, Abdel-Hady H, El-baz R, Saber I (2007) Gene polymorphisms of TNF-α (−308), IL-10 (−1082), and IL-1Ra (VNTR) related to susceptibility and severity of rheumatic heart disease. Pediatr Cardiol 28:363–371PubMedCrossRef
32.
Zurück zum Zitat Van Deventer SJ (2000) Cytokine and cytokine receptor polymorphisms in infectious disease. Intensive Care Med 26(Suppl 1):S98–S102PubMedCrossRef Van Deventer SJ (2000) Cytokine and cytokine receptor polymorphisms in infectious disease. Intensive Care Med 26(Suppl 1):S98–S102PubMedCrossRef
33.
Zurück zum Zitat Wilson AG, Symons JA, McDowel TL, McDevit HO, Duff GW (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 94:3195–3199PubMedCrossRef Wilson AG, Symons JA, McDowel TL, McDevit HO, Duff GW (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 94:3195–3199PubMedCrossRef
Metadaten
Titel
Role of cytokine gene (IFN-γ, TNF-α, TGF-β1, IL-6, and IL-10) polymorphisms in pathogenesis of acute rheumatic fever in Turkish children
verfasst von
Nilgun Col-Araz
Sacide Pehlivan
Osman Baspinar
Sibel Oguzkan-Balci
Tugce Sever
Ayse Balat
Publikationsdatum
01.07.2012
Verlag
Springer-Verlag
Erschienen in
European Journal of Pediatrics / Ausgabe 7/2012
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-012-1689-5

Weitere Artikel der Ausgabe 7/2012

European Journal of Pediatrics 7/2012 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.